| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Self Improvement > Leadership > Leadership 8 - Share Power |
|
Advice Pool - Leadership 8 - Share Power
This is the eighth part of a 10-part series on good leadership. A team is only as strong as its weakest member? If this is true, then winning teams will have all the According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product top players. Fortunately for many of us, this is not true. A team is as strong as its ability to harness the power of ALL its members. In our previous segment, Leader ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ship #7: Promote Cooperation and Trust in your Team, we spoke about cooperation among team members, and also about the supreme importance of building trust. Why is thi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. s important? The answer is simply this - if you don’t trust someone, you are not going to share your power with him or her. This is really fundamental to our human psy here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe che. There are teams which succeed very well under the leadership of a very strong individual. However, such teams will find it difficult to sustain its high performa d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro nce. With only one or two person bearing the load of leadership, it will not be long before exhaustion sets in. Exhaustion in terms of creativity, dynamism, clarity of ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc vision, taking risks and in the other myriad areas which require excellence in the team. A good leader understands the power of sharing power. When you assign decisi easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi n making authority to another team member, it does not reduce your power. Instead, it increases the overall decision making power of the team. Good leaders recognise t nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically his truth. Weak leaders fear this truth. Good decision making can be done by anyone with the appropriate training and the right information. The “best decision” is a f and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ allacy propagated by weak and fearful leaders who want to hoard the power and paint the illusion that they are the only ones capable of coming to the “best decision”. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi There is a consequence of sharing power that leaders must know. The ones to whom you have shared your powers to, will actually have a chance to grow and develop. They ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a will grow and become more powerful. They will be strengthened. On top of that, if you add good guidance and proper processes to aid them, they themselves can become a dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod cknowledged leaders in their own right. Good leaders strive to achieve this. Weak leaders secretly dread the day a “subordinate” is able to match their own skills and cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin knowledge. While there are many courses and workshops or seminars that teach leadership, the fact is; the single best way to train to become a leader is to actually h tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ve the opportunity to be a leader. By sharing power, a good leader not only strengthens the group’s effectiveness, he also strengthens the individual. What do we want t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel to achieve as a leader? If simply leading an effective group is sufficient, you probably could do just as well reading only up to Part 7 - Promote Cooperation and Tru ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust st in your Team ; however, if you want to achieve excellence as a leader, this is probably one of the most important aspects. In the long run, leaders are remembered f y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products or their achievements. But great leaders are remembered for their inspiration. To catch up, here are the links to the previous posts:
. As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de late Your Personal Vision As a Leader
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e Vision
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Why Discussion Fails in Meetings How Wireless Internet Phones Work Irritable Bowel Syndrome Explained
|